BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9664509)

  • 1. In vitro transcription/translation analysis for the identification of translation-terminating mutations.
    Luce MC; Binnie CG; Kam-Morgan LN; Cayouette MC
    Methods Mol Biol; 1998; 92():127-44. PubMed ID: 9664509
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular biology diagnosis of hereditary non-polyposis colorectal cancer (HNPCC)].
    Roqué M; Pusiol E; Perinetti H; Mayorga L
    Acta Gastroenterol Latinoam; 1999; 29(5):341-4. PubMed ID: 10668072
    [No Abstract]   [Full Text] [Related]  

  • 3. A double germline mutations in the APC and p53 genes.
    Zajac V; Tomka M; Ilenciková D; Májek P; Stevurková V; Kirchhoff T
    Neoplasma; 2000; 47(6):335-41. PubMed ID: 11263856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New mutation in the hMSH2 gene in a Spanish Muir-Torre syndrome.
    Caldés T; Godino J; Perez-Segura P; de la Hoya M; Diaz-Rubio E; Benito M
    Am J Gastroenterol; 2000 Sep; 95(9):2389-90. PubMed ID: 11007253
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
    Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
    Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of K-ras and beta-catenin genes related to O6-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma.
    Kohya N; Kitajima Y; Kitahara K; Miyazaki K
    Int J Mol Med; 2003 Jan; 11(1):65-9. PubMed ID: 12469220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations.
    Kahmann S; Herter P; Kuhnen C; Müller KM; Muhr G; Martin D; Soddemann M; Müller O
    Hum Mutat; 2002 Feb; 19(2):165-72. PubMed ID: 11793475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial adenomatous polyposis coli: five novel mutations in exon 15 of the adenomatous polyposis coli (APC) gene in Italian patients. Mutations in brief no. 225. Online.
    Scarano MI; De Rosa M; Panariello L; Carlomagno N; Riegler G; Rossi GB; Bucci L; Pesce G; Toni F; Renda A; Izzo P
    Hum Mutat; 1999; 13(3):256-7. PubMed ID: 10090483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
    Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
    J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nine novel APC mutations in Italian FAP patients.
    Resta N; Stella A; Susca F; Montera M; Gentile M; Cariola F; Prete F; Tenconi R; Tibiletti MG; Logrieco G; Mattina T; Andriulli G; Caruso ML; Fiorente P; Russo S; Caputi-Jambrenghi O; Mareni C; Guanti G
    Hum Mutat; 2001 May; 17(5):434-5. PubMed ID: 11317365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
    Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of germline mutations in the APC gene with the protein truncation test].
    Liu XR; Shan XN; Friedl W; Uhlhaas S; Li JT; Propping P; Wang YP
    Yi Chuan Xue Bao; 2005 Sep; 32(9):903-8. PubMed ID: 16201232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
    Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
    Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach.
    Liu WH; Kaur M; Makrigiorgos GM
    Hum Mutat; 2003 May; 21(5):535-41. PubMed ID: 12673796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-throughput nonisotopic protein truncation test.
    Gite S; Lim M; Carlson R; Olejnik J; Zehnbauer B; Rothschild K
    Nat Biotechnol; 2003 Feb; 21(2):194-7. PubMed ID: 12524552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
    Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
    Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA mismatch repair and colorectal cancer.
    Toft NJ; Arends MJ
    J Pathol; 1998 Jun; 185(2):123-9. PubMed ID: 9713337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.